AGP China Technology Report - Robotics in Surgery & Healthcare

Table of Contents

Page     Section
03          Technology Overview  
06          Historical Development Timeline  
10          Product Differentiation            
16          China Technology Ecosystem        
19          Sino-Foreign Collaboration        
22          Common Applications In China        
29          Government Policy Support        
32          Impact On Market Incumbents        
35          Final Conclusion                
36          Appendices      

1.1 Global Snapshot

Definition and Key Technologies

Robotics in surgery and healthcare encompasses the use of robotic systems to assist medical professionals in performing surgical procedures, diagnostics, rehabilitation, and patient care. These systems enhance precision, flexibility, and control, leading to improved patient outcomes and operational efficiency. Key technologies integral to these systems include:

• Actuators: Provide precise movement and control of robotic arms and instruments.
• Sensors: Enable real-time feedback and monitoring, ensuring accuracy and safety during procedures.
• Artificial Intelligence (AI) and Machine Learning (ML): Facilitate decision-making, image recognition, and adaptive learning capabilities.
• Imaging Systems: High-definition 3D imaging and visualization tools assist in planning and executing complex procedures.
• Control Systems: User interfaces and consoles that allow surgeons to operate robotic systems with enhanced dexterity.

Global Market Overview

The global surgical robotics market has experienced significant growth, driven by technological advancements and increasing adoption of minimally invasive procedures. In 2022, the market was valued at approximately USD 6.4 billion and is projected to reach USD 14.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.5%.

North America leads the market, accounting for approximately 45% of total revenue in 2023, followed by Europe (28%) and Asia Pacific (15%). The Asia Pacific region is the fastest-growing, with a projected CAGR of 12% during the forecast period.

Key Players and Innovations

Prominent companies in the surgical robotics sector include:

• Intuitive Surgical: Developer of the da Vinci Surgical System, a pioneer in robotic-assisted surgery.
• Medtronic: Offers the HugoTM robotic-assisted surgery system, expanding its presence in minimally invasive surgery.
• Stryker Corporation: Provides the Mako robotic-arm assisted surgery platform, primarily for orthopedic procedures.

Recent innovations focus on integrating AI and ML to enhance surgical precision, incorporating advanced imaging systems for better visualization, and developing modular robotic systems to increase versatility and cost- effectiveness.

1.2 China Snapshot

Market Position and Growth

China's surgical robotics market is expanding rapidly, driven by increasing healthcare investments, a growing aging population, and a rising prevalence of chronic diseases. In 2024, the market generated revenue of USD 120.1 million and is expected to reach USD 287.9 million by 2030, growing at a CAGR of 15.1% from 2025 to 2030.

Domestic Capabilities and Leading Firms

China has been enhancing its domestic capabilities in core components such as actuators, sensors, and control systems. Leading domestic firms include:

• Beijing Kangxin: Integrates advanced AI technology into its robotic systems, improving surgical outcomes.
• Zhuoer Medical: Offers innovative solutions tailored for local healthcare needs, gaining traction in the market.

These companies focus on developing cost-effective and versatile robotic systems to cater to the diverse needs of China's healthcare sector.

National Policies and Industrial Targets

The Chinese government has implemented policies to promote the development and adoption of surgical robotics. Initiatives include:

• Made in China 2025: A strategic plan aiming to upgrade the manufacturing capabilities of Chinese industries, including medical devices and robotics.
• Healthy China 2030: A policy framework emphasizing the importance of advanced medical technologies to improve healthcare services.

These policies support research and development, facilitate regulatory approvals, and encourage the integration of robotics into healthcare facilities.

Application Scaling and Cost-Performance Edge

China's cost-performance advantage is evident in the development of affordable robotic systems without compromising quality. This approach facilitates widespread adoption across various healthcare settings, including tertiary hospitals and smaller clinics. Applications include:

• Minimally Invasive Surgeries: Robotic systems are increasingly used in procedures such as laparoscopic surgeries, reducing recovery times and improving patient outcomes.
• Rehabilitation: Robotic-assisted rehabilitation devices aid in physical therapy, enhancing recovery for patients with mobility impairments.
• Elder Care: Robotic systems assist in elder care facilities, providing support for daily activities and monitoring health parameters.

Alignment with National Goals

The adoption of surgical robotics aligns with China's national goals of advancing "new productive forces" (新质生 产力), addressing demographic shifts, and promoting industrial upgrading. By integrating robotics into healthcare, China aims to:

• Enhance Healthcare Quality: Improve surgical precision and patient outcomes.
• Address Aging Population Needs: Provide efficient healthcare solutions for an increasing elderly population.
• Promote Technological Innovation: Foster the development of high-tech industries and reduce reliance on imported medical devices.

1.3 Market Size

Global Market Estimates

The global surgical robotics market is projected to experience substantial growth:

• ResearchAndMarkets.com: Estimates the market will reach USD 16.51 billion by 2030, expanding at a CAGR of 17.16% from 2023.
• MarketsandMarkets: Projects the market to grow from USD 11.1 billion in 2024 to USD 23.7 billion by 2029, at a CAGR of 16.5%.
• Allied Market Research: Forecasts the market to reach USD 188.8 billion by 2032, growing at a CAGR of 9.1%.

China-Specific Estimates

China's surgical robotics market is also expected to grow significantly:

• Grand View Research: Reports the market generated USD 120.1 million in 2024 and is projected to reach USD 287.9 million by 2030, with a CAGR of 15.1% from 2025 to 2030.
• Market Research Future: Estimates the market size to be USD 209.25 million in 2023, reaching USD 1,059.08 million by 2035, at a CAGR of 14.287% from 2025 to 2035.

Growth Scenarios

Three potential growth scenarios for the surgical robotics market include:

• High Growth: Rapid technological advancements, favorable regulatory environments, and increased healthcare investments lead to accelerated adoption and market expansion.
• Medium Growth: Steady technological progress and moderate investment result in consistent market growth aligned with current projections.
• Low Growth: Challenges such as high costs, regulatory hurdles, and limited skilled personnel slow adoption, leading to subdued market growth.

Market Segmentation

The surgical robotics market can be segmented by:

• Application Domain: Orthopedics, neurology, urology, gynecology, and general surgery.
• End User: Hospitals, ambulatory surgical centers, and specialty clinics.
• Geography: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Understanding these segments helps stakeholders identify growth opportunities and tailor strategies to specific market needs.